Aktienanalyse zu SS Innovations International Inc (SSII)SSIISS Innovations International Inc

SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset. It operates in the Healthcare sector.

SS Innovations International Inc (SSII) is currently not a good buy due to its significant price decline of 60.18% year-to-date and an RSI of 21.231, indicating it is oversold. Although the company has a promising new CFO with extensive experience and a strong analyst price target of $7, the recent performance and negative earnings trends present substantial risks. The main risk is the negative net income reported in the last quarter, which was -2,661,350 USD, reflecting ongoing financial struggles.